Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AIM ImmunoTech Inc. Common Stock (NY:AIM)

0.6012 -0.1288 (-17.64%)
Streaming Delayed Price Updated: 10:28 AM EDT, Jun 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about AIM ImmunoTech Inc. Common Stock

News headline image
Stocks Under $1: NXXT, TOON, VRAX, AIM, SBFM on Breakout Watch
Via AB Newswire
Topics Artificial Intelligence Intellectual Property
News headline image
AIM ImmunoTech Announces Election of Three Incumbent Board Members at Annual Meeting
From AIM ImmunoTech Inc.
Via Business Wire
News headline image
AIM ImmunoTech Reminds Shareholders to Vote “FOR” All Four Incumbent Board Members on the WHITE Universal Proxy Card
From AIM ImmunoTech Inc.
Via Business Wire
News headline image
AIM ImmunoTech Urges Shareholders to Vote on the WHITE Universal Proxy Card “FOR” All Four Incumbent Board Members
From AIM ImmunoTech Inc.
Via Business Wire
News headline image
Glass Lewis Recommends AIM ImmunoTech Shareholders Vote “FOR” Company Nominees Nancy K. Bryan, Thomas K. Equels and Dr. William M. Mitchell
From AIM ImmunoTech Inc.
Via Business Wire
News headline image
ISS Recommends AIM ImmunoTech Shareholders Vote “FOR” Company Nominees Nancy K. Bryan and Dr. William M. Mitchell
From AIM ImmunoTech Inc.
Via Business Wire
News headline image
AIM ImmunoTech Issues Presentation Detailing Why Shareholders Should NOT Elect Activist Group’s Nominees to the Board
From AIM ImmunoTech Inc.
Via Business Wire
News headline image
AIM ImmunoTech Refutes Activist Group’s False and Misleading Claims
From AIM ImmunoTech Inc.
Via Business Wire
News headline image
AIM ImmunoTech Announces Cash Conservation Plan
From AIM ImmunoTech Inc.
Via Business Wire
News headline image
AIM ImmunoTech Issues Presentation Detailing Case for Re-Electing Current Directors to Oversee Continued Momentum and Drive Strategy to Create Long-Term Value for Patients and Shareholders
From AIM ImmunoTech Inc.
Via Business Wire
News headline image
AIM ImmunoTech Files Definitive Proxy Statement and Sends Letter to Shareholders
From AIM ImmunoTech Inc.
Via Business Wire
News headline image
AIM Shareholders Elect All Four Company Director Nominees at 2023 Annual Meeting
From AIM ImmunoTech Inc.
Via Business Wire
News headline image
Delaware Court Rules in Favor of AIM ImmunoTech and Upholds Board’s Determination that Activist Group’s Nominations Are Invalid
From AIM ImmunoTech Inc.
Via Business Wire
News headline image
AIM ImmunoTech Provides Update Regarding Annual Meeting
From AIM ImmunoTech Inc.
Via Business Wire
News headline image
AIM ImmunoTech Files Definitive Proxy Statement and Sends Letter to Shareholders
From AIM ImmunoTech Inc.
Via Business Wire
News headline image
AIM ImmunoTech Rejects Director Nomination Notice from Activist Group Due to Numerous Material Defects, Omissions and False and Misleading Statements
From AIM ImmunoTech Inc.
Via Business Wire
Rise in Biotech Innovations Generating Hope as Pancreatic Cancer Survival Rates Climb
FN Media Group Presents USA News Group News Commentary Vancouver, BC – March 14, 2023 – USA News Group – Optimism is on the rise as the American Cancer Society is reporting that the five-year survival... 
Via FinancialNewsMedia
News headline image
JTC Team to Host the Virtual Investor 2023 Companies to Watch Event on January 17th, 18th, and 19th
Via ACCESSWIRE
News headline image
AIM ImmunoTech Announces Corporate Governance Enhancements
From AIM ImmunoTech Inc.
Via Business Wire
News headline image
AIM ImmunoTech Shareholders Elect All Three Company Director Nominees at 2022 Annual Meeting
From AIM ImmunoTech Inc.
Via Business Wire
News headline image
Delaware Court Rules in Favor of AIM ImmunoTech and Declines to Declare Activist Group’s Nominations Valid
From AIM ImmunoTech Inc.
Via Business Wire
News headline image
AIM ImmunoTech Board Issues Letter to Shareholders
From AIM ImmunoTech Inc.
Via Business Wire
News headline image
AIM ImmunoTech Board Files Definitive Proxy Statement and Sends Letter to Shareholders
From AIM ImmunoTech Inc.
Via Business Wire
News headline image
AIM ImmunoTech Provides Update on Jorgl Activist Group Litigation
From AIM ImmunoTech Inc.
Via Business Wire
News headline image
JTC Team to Host Virtual Investor 2022 Top Picks Conference on January 25th, 26th, and 27th
- Access the event and schedule of presenting companies at virtualinvestorco.com - - Live video webcast presentations of participating companies followed by interactive Q&A session - PITTSTOWN, NJ /... 
From JTC Team, LLC
Via AccessWire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.